Afuresertib |
ASB-183; GSK-2110183; GSK-2110183B; GSK-2110183C; GSK-21110183; LAE-002 |
Phase 3 Clinical |
Glaxosmithkline Plc, Novartis Pharma Ag |
Breast Neoplasms; Adenocarcinoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell; Endometrial Neoplasms; Metastatic breast cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Hematologic Neoplasms; Histiocytosis, Langerhans-Cell; Multiple Myeloma; Triple Negative Breast Neoplasms; Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Solid tumours; Ovarian Neoplasms |
Details
|
Ipatasertib Dihydrochloride |
RG-7440; GCD-0068; GDC-0068; RO-5532961 |
Phase 3 Clinical |
Array Biopharma, F. Hoffmann-La Roche Ltd |
Paranasal Sinus Neoplasms; Hepatic Insufficiency; Urogenital Neoplasms; Neoplasms, Unknown Primary; Endometrial Neoplasms; Carcinoma, Squamous Cell; Lip Neoplasms; Laryngeal Neoplasms; Mouth Neoplasms; Peritoneal Neoplasms; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Paranasal Sinus Diseases; Uterine Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Endometrioid; Adenocarcinoma; Glioblastoma; Solid tumours; Neoplasm, Residual; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Cystadenocarcinoma, Serous; Triple Negative Breast Neoplasms; Neoplasms; Ovarian Neoplasms; Hypopharyngeal Neoplasms; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Prostatic Neoplasms; Cholangiocarcinoma; Genital Neoplasms, Female; Oropharyngeal Neoplasms |
Details
|
TIC-10 |
ONC201 - Oncoceutics; ONC201/TIC10; NSC-350625; TIC-10; ONC-201 |
Phase 3 Clinical |
Oncoceutics Inc |
Diffuse Intrinsic Pontine Glioma; Central Nervous System Lymphoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Meningioma; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Adenomatous Polyps; Endometrial Neoplasms; Glioma; Gliosarcoma; Colorectal Neoplasms; Adenomatous Polyposis Coli; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Mantle-Cell; Breast Neoplasms; Multiple Myeloma; Neoplasms; Myelodysplastic Syndromes; Triple Negative Breast Neoplasms; Thalamic Diseases; Glioblastoma; Diffuse midline glioma; Solid tumours |
Details
|
Triciribine Phosphate |
NSC-154020; PTX-002; API-2; TCN-P; VQD-002-ORAL; VQD-002; NSC-280594; PTX-200 |
Phase 2 Clinical |
National Cancer Institute |
Ovarian Neoplasms; Hematologic Neoplasms; Leukemia; Neoplasms; Breast Neoplasms |
Details
|
Miransertib |
MK-7075; ARQ-092 |
Phase 2 Clinical |
Arqule Inc |
Proteus Infections; Solid tumours; Ovarian Neoplasms; Neoplasms; PIK3CA-Related Overgrowth Spectrum; Proteus Syndrome; Lymphoma; Endometrial Neoplasms |
Details
|
Iopofosine I-131 |
CLR-131; NM404; (131)I-CLR1404; 131I-NM-404; HOT; CLR1404 I-131; I-131-CLR1404; (131)I-NM 404 |
Phase 2 Clinical |
University Of Michigan |
Neuroblastoma; Central Nervous System Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Glioma; Waldenstrom Macroglobulinemia; Diffuse Intrinsic Pontine Glioma; Sarcoma, Ewing; Brain Neoplasms; Lymphoma, B-Cell, Marginal Zone; Osteosarcoma; Lymphoma, Mantle-Cell; Multiple Myeloma; Neoplasms; Lymphoma, Large B-Cell, Diffuse; Rhabdomyosarcoma; Solid tumours; Head and Neck Neoplasms |
Details
|
Uprosertib/Trametinib Dimethyl Sulfoxide |
|
Phase 2 Clinical |
Novartis Pharma Ag |
Leukemia, Myeloid, Acute; Endometrial Neoplasms; Uterine Cervical Neoplasms |
Details
|
TAS-117 |
TAS-117 |
Phase 2 Clinical |
Otsuka Pharmaceutical Co Ltd, Taiho Pharmaceutical Co Ltd |
Solid tumours |
Details
|
Selumetinib sulfate/MK-2206 |
|
Phase 2 Clinical |
Astrazeneca Plc, Merck & Co Inc |
Rectal Neoplasms; Triple Negative Breast Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma |
Details
|
Uprosertib |
GSK-795; GSK-2141795; GSK-2141795C; UPB-795 |
Phase 2 Clinical |
Glaxosmithkline Plc, Novartis Pharma Ag, National Cancer Institute |
Solid tumours; Hematologic Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Multiple Myeloma; Breast Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Uterine Neoplasms; Endometrial Neoplasms; Uterine Cervical Neoplasms; Melanoma; Adenocarcinoma |
Details
|
RX-0301 |
RX-0301; WGI-0301; RX-0201 nanoliposomal; RX-0201 Nano; RX-0201-N; RX-0201改良型; HC0301 |
Phase 2 Clinical |
Rexahn Pharmaceuticals Inc |
Liver Neoplasms; Solid tumours; Carcinoma, Hepatocellular |
Details
|
MK-2206 |
NSC-749607; BIND-2206; MK2206; MK-2206 |
Phase 2 Clinical |
Merck Sharp & Dohme Corp |
Leukemia, Myelomonocytic, Juvenile; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Neoplasms, Gonadal Tissue; Gallbladder Neoplasms; Burkitt Lymphoma; Endometrial Neoplasms; Lymphoma, T-Cell; Waldenstrom Macroglobulinemia; Lymphoma; Leukemia, Monocytic, Acute; Glioma; Peritoneal Neoplasms; Adenocarcinoma, Bronchiolo-Alveolar; Colorectal Neoplasms; Sezary Syndrome; Leukemia, Myeloid, Chronic-Phase; Bile Duct Neoplasms; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Lymphoproliferative Disorders; Cholangiocarcinoma; Carcinoma, Adenosquamous; Adenocarcinoma; Breast Neoplasms, Male; Mycosis Fungoides; Melanoma; Leukemia, Prolymphocytic; Leukemia, T-Cell; Carcinoma, Non-Small-Cell Lung; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Central Nervous System Lymphoma; Carcinoma, Hepatocellular; Breast Neoplasms; Lymphoma, T-Cell, Cutaneous; Lymphoma, Large-Cell, Anaplastic; Adenocarcinoma, Mucinous; Thymoma; Lung Neoplasms; Leukemia, Myeloid, Acute; Fallopian Tube Neop |
Details
|
NTQ-1062 |
NTQ-1062; NTQ1062 |
Phase 2 Clinical |
Nanjing Zhengda Tianqing Pharmaceutical Co Ltd |
Solid tumours; Breast Neoplasms; HR-positive breast cancer |
Details
|
HZB-0071 |
HZB-0071 |
Phase 1 Clinical |
Wuxi Apptec Co Ltd, Heilongjiang Zbd Pharmaceutical Co Ltd |
Neoplasms |
Details
|
Rupitasertib |
DIACC3010; M-2698; MSC-2363318A; DIACC-3010 |
Phase 1 Clinical |
Emd Serono Inc |
Solid tumours; Stomach Neoplasms; Glioblastoma; Breast Neoplasms |
Details
|
Honokiol |
HU-002; JRF-101 |
Phase 1 Clinical |
Anacor Pharmaceuticals Inc |
Metabolic Dysfunction-Associated Steatotic Liver Disease; Gingival Diseases; Carcinoma, Non-Small-Cell Lung |
Details
|
CMX-2043 |
LIP-EA; CMX-2043; R-LIP-EA-OH |
Phase 1 Clinical |
Ischemix Llc |
Brain Injuries, Traumatic; Angina, Unstable; Coronary Artery Disease |
Details
|
Hu-7691 |
Hu-7691 |
Phase 1 Clinical |
Zhejiang University |
Solid tumours; Neoplasms |
Details
|
Oxysterols (Intsel Chimos) |
|
Clinical |
Centre National De La Recherche Scientifique (Cnrs) |
Glioma |
Details
|